KhanhC.Hoang

Gene Therapy is a high risk high reward

Alış
KhanhC.Hoang Güncellendi   
NASDAQ:SELB   None
back in Oct 2020 -> "an early Moderna (MRNA) investor and Harvard PhD, Timothy Springer, continued to pour his fortune into this small cap stock. Mr. Springer also happens to be a director at Selecta Biosciences. He reportedly purchased more than 6,500,000 shares in October. He went on a shopping spree on October 7 when he bought 654,953 shares at $1.65 and continued buying all the way to October 23 when he bought 994,448 shares for $2.71."
Yorum:
daily chart for the initial entry

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.